Zelira Therapeutics Limited carries a market capitalization of 4.16M, placing it among publicly traded companies globally.
| Market Cap | 4.16M |
| Enterprise Value | N/A |
Zelira Therapeutics Limited's stock has gained approximately 25.35817% over the past 52 weeks. The 50-day moving average sits at 0.34, while the 200-day moving average is 0.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25.35817% |
| 50-Day Moving Average | 0.34 |
| 200-Day Moving Average | 0.30 |
| Average Volume (20 Days) | N/A |
Zelira Therapeutics Limited's most recent stock split took place on April 14, 2022 with a 175:1 split ratio.
| Last Split Date | 4/14/2022 |
| Split Ratio | 175:1 |